Erez Israeli, Dr. Reddy's CEO
Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M
Generic drugs giant Dr. Reddy’s Laboratories has made a deal to acquire Mayne Pharma’s US generics portfolio for at least $90 million.
Mayne Pharma sells …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
